Immuno-oncology Assays

Immuno-oncology applications
Request Information

Immunotherapy is advancing rapidly, creating lifesaving treatments that use the body’s own immune system to target and destroy tumors. Transform your immuno-oncology research and simplify your workflow with our easy-to-use immune cell killing assays. Quickly and efficiently assess potential candidates and reliable, functional data for decision making. Discover how Axion’s live-cell analysis platforms can accelerate your immunotherapy research and development—from investigating immunomodulators to evaluating CAR cell killing in solid and liquid tumors.

Immuno-oncology assays: Get more with live-cell analysis

There are many critical steps in development. The right assay can help you make the right choices.

Our live-cell assays capture the entire experiment. Analyze rate, duration, and magnitude with a single, easy assay.

Identify and prioritize candidates

  • Screen checkpoint inhibitors, compare CAR constructs, or test immunomodulators ​

Optimize your development process

  • Evaluate transduction methods, proliferation, or cryopreservation with clear functional data

Get reliable preclinical data​

  • No critical reagents to validate, just clean reproducible potency data with GMP compatible systems available.
Immune Cell Killing from discovery to manufacturing workflow

 

Explore more immuno-oncology assay:

 

CAR T Cells

CAR T Cell Killing Assay

T cells that recognize specific antigens on the tumor cell through genetically engineered receptors.  Learn more >> 

Natural Killer Cells

Natural Killer Cell Assay

NK cells are granular lymphocytes involved in the innate immune response to viruses and tumors. Learn more >> 

Antibody-dependent Cellular Cytotoxicity

Antibody-dependent Cellular Cytotoxicity (ADCC)

By binding to tumor cells, antibodies can enhance the recognition and killing by immune cells. Learn more >> 

Solid Tumor - Cancer Spheroids

Solid Tumor/Cancer Spheroid

Immune penetration and the tumor microenvironment can challenge immunotherapies. Investigate immune cell killing in cancer spheroids. Learn more >> 

Liquid Tumors

Liquid Tumor Assay

Liquid tumors such as leukemia, lymphoma, and myeloma are an important target in immuno-oncology. Learn more >> 

 

 

Webinar with Dr. Meghan Logun. Register by Nov. 5th 2024